rawfin.tv
United Therapeutics CEO Sells $4.7 Million in Company Stock
MarketsstocksAI Generated

United Therapeutics CEO Sells $4.7 Million in Company Stock

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Martine A. Rothblatt, CEO of United Therapeutics Corp. (UTHR), sold 9,500 shares of the company's stock, totaling approximately $4.74 million. This transaction represents an insider sale by a key executive.

United TherapeuticsInsider TradingStock SaleBiotech Sector

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks